Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Open-label, Single-Arm Phase Ib/II Study of Immune Combination Therapy with Elotuzumab and Belantamab Mafodotin in Patients with Relapsed Refractory Multiple Myeloma.

Sabrina Browning,Fangyong Li,Terri L. Parker,Noffar Bar,Tara Anderson,Erica Stevens,Jennifer VanOudenhove,Martin Matthews,Elan Gorshein,Ashita D. Talsania,Kert D. Sabbath,Stuart Seropian,Stephanie Halene,Natalia Neparidze

Journal of Clinical Oncology（2024）

Cited 0|Views0
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined